Cleared Traditional

K921038 - ECLIPSE 2100

K921038 is an FDA 510(k) clearance for ECLIPSE 2100, manufactured by Cardiogenes. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 92-day FDA review.

K921038 · Cardiogenes · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1992
Decision
92d
Days
Class 2
Risk

K921038 is an FDA 510(k) clearance for the ECLIPSE 2100. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Cardiogenes (Palo Alto, US). The FDA issued a Cleared decision on June 4, 1992 after a review of 92 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardiogenes devices

FDA 510(k) Submission Details - K921038

510(k) Number K921038 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 1992
Decision Date June 04, 1992
Days to Decision 92 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 115d · This submission: 92d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1639
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K921038.
SHARPLAN CO2 SURG. LASER, MO. 1039 SURGICENTER 40
K921146 · Sharplan Lasers, Inc. · Jun 1992
CANDELA PLTL-1 LASER SYSTEM: PIGMENTED LESION LAS.
K920062 · Candela Laser Corp. · Jun 1992
DAVOL ENDO-FLO LASER PROBE AND ACCESSORIES
K920659 · Davol, Inc. · Jun 1992
SHARPLAN C02 ULTRASWIFT VAPORIZATION ENDPIECE
K921596 · Sharplan Lasers, Inc. · May 1992
VERSAPULSE(TM) TWOPOINTONE/XE HOLMIUM SURG LASERS
K914991 · Coherent Medical Group · May 1992
ANGLED DELIVERY DEVICE
K920589 · Laserscope · Apr 1992